Beijing, China -- May 17, 2005 -- CapitalBio Corp. announces that it has received the CE Certification approval for its Microarray Scanner LuxScan 10K-A. Products successfully went through rigorous evaluation and testing to receive the CE Certificate. This regulatory milestone clears the way for CapitalBio to market its confocal dual laser microarray scanner throughout the European Union for microarray imaging which is useful for academic and industrial biomedical research and drug discovery.
May. 16th, 2005, In the article of "Can China Innovate?" of the recent TIME ASIA SCIENCE AND TECHNOLOGY report, several recent developments regarding CapitalBio Corp were reported. The article stated that, "In many ways, CapitalBio represents a template for China´s R&D future: just as companies have used China´s huge pools of labor to turn the country into the workshop of the world, so too can they take advantage of the nation´s enormous supply of cheap but talented engineers and scientists."
SANTA CLARA, Calif. and Beijing, P.R. CHINA, April 26, 2005 -- Affymetrix, Inc., (Nasdaq: AFFX) and CapitalBio Corporation, a leading life science company based in Beijing, P.R. China announced today that the two companies have entered into a strategic relationship. The agreement initially includes joint development of a proprietary, advanced GeneChip® -compatible personal scanner and a service provider program, through which CapitalBio will offer the full line of Affymetrix GeneChip products.